Legal News

Valeant Pharmaceuticals International Inc. Offers to Buy Botox Giant Allergan Inc.
Download PDF
1 Star2 Stars3 Stars4 Stars5 Stars (No Ratings Yet)

In a cash-and-stock deal valued at $45.7 billion, Valeant Pharmaceuticals Inc. would give Allergan investors $48.30 in cash and 0.83 percent in Valeant stock for each share they own. Pershing Square Capital Management LP, the fund run by Bill Ackman, Allergan’s largest shareholder, supports the deal.

According to a Statement by Valeant, the bid is a “substantial premium” on Allergan’s unaffected price of $116.63 on April 10, the day before Pershing crossed the 5 percent ownership level and commenced it’s rapid accumulation program.


A filing yesterday with the U.S Securities and Exchange Commission read, Valeant and Pershing Square’s, Ackman, think Allergan is undervalued, and an attractive investment. Pershing Square amassed 9.7 percent of Allergan after reaching an agreement with Valeant to jointly pursue a hostile takeover of the company.

“We firmly believe that combining Valeant and Allergan would create an unrivaled platform for growth and value creation in health care,” Valeant said in an email.

Valeant’s major emphasis in generic drugs has been expanded into specialty medicines such as, opthalmology, dermatology and dentistry. In 2008, when Chief Executive Officer, Mike Person took over, at least $19 billion was spent on more than 35 companies as part of Laval, Quebec-based Valeant’s goal to join in with the world’s largest drug makers.

Get JD Journal in Your Mail

Subscribe to our FREE daily news alerts and get the latest updates on the most happening events in the legal, business, and celebrity world. You also get your daily dose of humor and entertainment!!

“I don’t think it’s any secret that a combination of Valeant and Allergan would make a lot of sense,” Timothy Chiang, an analyst at CRT Capital Group LLC in Stamford Connecticut, said in a telephone interview. “The question has always been, it’s not whether Valeant would be interested in buying Allergan, it’s a question of would Allergan want to sell to Valeant.” A spokeswoman for Allergan, Bonnie Jacobs, did not respond for comment.

Looking for Pharmaceutical jobs? Click here.

Image credit:



Senior Counsel


Senior Counsel    About Us The Buried Alive Project is a non-profit criminal just...

Apply now

Associate Aviation Attorney


Qualifications Private Pilot Certification (Required) Full Job Descr...

Apply now

Legal Assistant


Description      An AV-rated Civil Litigation Firm, specializing in real property,...

Apply now

Associate Attorney- Litigation


About the Job: Established AV-rated Missoula law firm is seeking an articulate and ambitious asso...

Apply now




Search Now

Junior to Mid-level Cybersecurity, Privacy and Technology Associate Attorney

USA-NY-Garden City

Garden City office of a BCG Attorney Search Top Ranked Law Firm seeks a junior to mid-level cybersec...

Apply Now

Patent Prosecution Attorney


Milwaukee office of a BCG Attorney Search Top Ranked Law Firm seeks patent prosecution attorney with...

Apply Now

Junior/Mid-level Trust and Estate Litigation Associate Attorney

USA-CA-San Diego

San Diego office of a BCG Attorney Search Top Ranked Law Firm seeks junior/mid-level trust and estat...

Apply Now

Most Popular


To Top